ArticleClinical drug investigation2022
Correction to: Efficacy and Safety Results from a Phase 2, Randomized, Double Blind Study of Enzalutamide Versus Placebo in Advanced Hepatocellular Carcinoma.
Baek-Yeol Ryoo et al.PubMed ↗Publisher ↗
No numbers read from the abstract.